Medical disclaimer

What this site is not

My Peptide Information is an educational publication. It is not a medical provider, a pharmacy or a prescriber. We do not diagnose, treat, prescribe or dispense. We do not manufacture or compound medication. Nothing here is medical advice and nothing here creates a clinician-patient relationship.

We cannot tell you whether a treatment is appropriate for you. That depends on your history, your current medications, your laboratory values and your goals, and it requires a licensed clinician who can examine you. A website is not a substitute for that, and any website implying otherwise is misleading you.

On compounded medication

Compounded medications are not FDA-approved as finished products. The FDA does not review them for safety, effectiveness or quality before they are marketed. We repeat this on every relevant page — not as a legal formality, but because it is the single most important fact for a reader in this category to hold.

On results

Trial results are averages across a studied population. Individual results vary widely, and a mean reduction of 20.9% in a trial is not a promise to you. We do not use words like 'guaranteed', 'risk-free' or 'works for everyone', and we would ask you to distrust any source that does.

In an emergency

If you are having a medical emergency, contact emergency services. Do not wait for a telehealth reply. Severe abdominal pain radiating to the back, persistent vomiting, signs of an allergic reaction, or an erection lasting more than four hours all warrant immediate care.

How this works in practice

A policy that is not operationalised is decoration. Here is what ours actually changes about the pages you read.

Every price carries a status. Verified means we hold a dated capture of the provider's own page. Reported — pending verification means a provider or third party reports it and we have not captured it ourselves. Evaluation in progress means we are not asserting it. We do not upgrade a price to Verified because a comparison site published it — sites in this category contradict each other routinely, and a number repeated by three affiliate blogs is still one unverified number.

Every medical claim traces to a primary source. FDA labels and guidance for regulatory status; PubMed-indexed randomised trials for efficacy; ClinicalTrials.gov for trial design. Reddit and patient forums are never used as evidence of price, safety, efficacy or legitimacy — they may be described as anecdotal sentiment, labelled as such. Animal research is never presented as proof of a human clinical effect.

Every ranking shows its arithmetic. Where a provider we have a commercial relationship with ranks well, the calculation that produced that result is printed on the page. If the arithmetic is wrong, you can see that it is wrong, and tell us.

Commercial relationships and what they do not buy

The publisher and certain principals have financial relationships with some of the telehealth providers listed on this site, and we may earn a commission when readers use certain links. That is how this publication is funded, and we state it in the footer of every page rather than burying it.

What compensation does not do: it does not change a score, a rank, an inclusion decision, or a negative finding. Providers cannot pay for placement, cannot suppress an accurate criticism, and cannot review their own page before publication. Where a commercially-related provider loses a category, we say so — a comparison in which one provider wins everything is an advertisement, and the fastest way to tell the difference is to look for the losses.

Corrections

We publish prices in a market that changes them frequently, and we will get things wrong. When we do, we correct the page, date the correction, and say what changed — we do not quietly edit a number and pretend it was always right. Both readers and providers can submit corrections with evidence, through the same process and to the same standard.

Our own record so far includes removing a set of provider prices we had sourced from a third-party comparison site and could not substantiate, and correcting brand-pricing figures that had gone stale after a manufacturer price cut. Both corrections made the site less flattering to conclusions we had already published. That is the point.